Additionally, studies show that high expression of EZH2 is related to bad prognosis in prostate cancer, and it is also an indicator to distinguish indolent prostate cancer from prostate cancer with lethal evolution [57]. The gene discussed is EZH2; the disease is prostate carcinoma.